Cited by 1,947Receptor Mechanisms and SignalingIon channel regulation and functionNeuroscience and Neuropharmacology Research

The DOI matches its Crossref record; 3 of the 7 references it cites were found in a registry or an index, and 4 are not checked yet.

Guide to Receptors and Channels (GRAC), 5th edition

Open access

Alexander, SPH, Mathie, A, Peters, JA·2011·British Journal of Pharmacology

DOI 10.1111/j.1476-5381.2011.01649_1.xPMC PMC3315626

Open this paper in CoChat — free account Open PDF

Abstract

The Fifth Edition of the 'Guide to Receptors and Channels' is a compilation of the major pharmacological targets divided into seven sections: G protein-coupled receptors, ligand-gated ion channels, ion channels, catalytic receptors, nuclear receptors, transporters and enzymes. These are presented with nomenclature guidance and summary information on the best available pharmacological tools, alongside suggestions for further reading. Available alongside this publication is a portal at http://www.GuideToPharmacology.org which is produced in close association with NC-IUPHAR and allows free online access to the information presented in the Fifth Edition.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1111/j.1476-5381.2011.01649_1.x

Cites

3 of 7 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The glutamate/neutral amino acid transporter family SLC1: molecular, physiological and pharmacological aspects
Kanai, Y., & Hediger, M. A. (2004) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s00424-003-1146-4 · Cited by 450
The thermo‐TRP ion channel family: properties and therapeutic implications
Vay, L., Gu, C., & McNaughton, P. A. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01601.x · Cited by 313
Guide to Receptors and Channels (GRAC), 4th edition
Alexander, S. P. H., & Peters, J. A. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00499.x · Cited by 249
Self-citation
The oligomeric state sets GABAB receptor signalling efficacy
Comps‐Agrar, L., Kniazeff, J., Nørskov-Lauritsen, L., Maurel, D., Gassmann, M., Gregor, N., Prézeau, L., Bettler, B., Durroux, T., Trinquet, E., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.143 · Cited by 103
Design and synthesis of the CB1 selective cannabinoid antagonist AM281: A potential human SPECT ligand
Lan, R., Lu, Q., Fan, P., Gatley, J. S., Volkow, N. D., Fernando, S. R., Pertwee, R. G., & Makriyannis, A. (1999) · AAPS PharmSci · doi:10.1208/ps010204 · Cited by 98
X. International Union of Pharmacology recommendations for nomenclature of new receptor subtypes.
Vanhoutte, P. M., Humphrey, P. P. A., & Spedding, M. (1996) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06936-4 · Cited by 78
The VPAC 2 agonist peptide histidine isoleucine (PHI) up‐regulates glutamate transport in the corpus callosum of a rat model of amyotrophic lateral sclerosis (hSOD1 G93A ) by inhibiting caspase‐3 mediated inactivation of GLT‐1a
Goursaud, S., Focant, M. C., Berger, J. V., Nizet, Y., Maloteaux, J., & Hermans, E. (2011) · The FASEB Journal · doi:10.1096/fj.11-182337 · Cited by 14

Show all 2 references

Sorted by citations

ChEMBL: a large-scale bioactivity database for drug discovery
Gaulton, A., Bellis, L. J., Bento, A. P., Chambers, J., Davies, M., Hersey, A., Light, Y., McGlinchey, S., Michalovich, D., Al-Lazikani, B., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr777 · Cited by 4,382
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2
Pertwee, R. G., Howlett, A. C., Abood, M. E., Alexander, S. P. H., Marzo, V. D., Elphick, M. R., Greasley, P. J., Hansen, H. S., Kunos, G., Mackie, K., et al. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.003004 · Cited by 1,666
Self-citation
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects.
Russo, E. B. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01238.x · Cited by 1,535
The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands
Pawson, A. J., Sharman, J. L., Benson, H. E., Faccenda, E., Alexander, S. P. H., Buneman, O. P., Davenport, A. P., McGrath, J. C., Peters, J. A., Southan, C., et al. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt1143 · Cited by 845
Self-citation
Pharmacological characterization of designer cathinonesin vitro
Simmler, L. D., Buser, T., Donzelli, M., Schramm, Y., Dieu, L., Huwyler, J., Chaboz, S., Hoener, M. C., & Liechti, M. E. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02145.x · Cited by 696
Ligand binding assays at equilibrium: validation and interpretation
Hulme, E. C., & Trevethick, M. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00604.x · Cited by 687
Incidence, reversal, and prevention of opioid-induced respiratory depression
Dahan, A., Aarts, L., & Smith, T. W. (2010) · Anesthesiology · doi:10.1097/aln.0b013e3181c38c25 · Cited by 634
CB2: a cannabinoid receptor with an identity crisis
Atwood, B. K., & Mackie, K. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00729.x · Cited by 658
The selectivity of β‐adrenoceptor agonists at human β1‐, β2‐ and β3‐adrenoceptors
Baker, J. G. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00754.x · Cited by 591
Anxiety, depression, and the microbiome: A role for gut peptides
Lach, G., Schellekens, H., Dinan, T. G., & Cryan, J. F. (2018) · Neurotherapeutics · doi:10.1007/s13311-017-0585-0 · Cited by 573
Neuropeptide, Y, peptide YY and pancreatic polypeptide in the gut-brain axis
Holzer, P., Reichmann, F., & Farzi, A. (2012) · Neuropeptides · doi:10.1016/j.npep.2012.08.005 · Cited by 501
Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase‐activating polypeptide: IUPHAR Review 1
Harmar, A. J., Fahrenkrug, J., Gozes, I., Laburthe, M., May, V., Pisegna, J. R., Vaudry, D., Vaudry, H., Waschek, J. A., & Said, S. I. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01871.x · Cited by 482
Neuropeptides and the Microbiota-Gut-Brain Axis
Holzer, P., & Farzi, A. (2014) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4939-0897-4_9 · Cited by 451
FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system
Brinkmann, V. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00451.x · Cited by 442
Emerging strategies for exploiting cannabinoid receptor agonists as medicines
Pertwee, R. G. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00048.x · Cited by 436
Plant derived substances with anti-cancer activity: from folklore to practice
Fridlender, M., Kapulnik, Y., & Koltai, H. (2015) · Frontiers in Plant Science · doi:10.3389/fpls.2015.00799 · Cited by 433
Allosteric modulators of NR2B‐containing NMDA receptors: molecular mechanisms and therapeutic potential
Mony, L., Kew, J. N. C., Gunthorpe, M. J., & Paoletti, P. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00304.x · Cited by 420
Estrogen biology: New insights into GPER function and clinical opportunities
Prossnitz, E. R., & Barton, M. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.02.002 · Cited by 404
A guide to plasma membrane solute carrier proteins
Pizzagalli, M. D., Bensimon, A., & Superti‐Furga, G. (2020) · FEBS Journal · doi:10.1111/febs.15531 · Cited by 409
Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity
Haas, E., Bhattacharya, I., Brailoiu, E., Damjanović, M., Brailoiu, G. C., Gao, X., Mueller-Guerre, L., Marjon, N. A., Gut, A., Minotti, R., et al. (2009) · Circulation Research · doi:10.1161/circresaha.108.190892 · Cited by 373
Antidepressant‐like effects of cannabidiol in mice: possible involvement of 5‐HT1Areceptors
Zanelati, T., Biojone, C., Moreira, F., Guimarães, F., & Joca, S. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00521.x · Cited by 366
TGFα shedding assay: an accurate and versatile method for detecting GPCR activation
Inoue, A., Ishiguro, J., Kitamura, H., Arima, N., Okutani, M., Shuto, A., Higashiyama, S., Ohwada, T., Arai, H., Makide, K., et al. (2012) · Nature Methods · doi:10.1038/nmeth.2172 · Cited by 361
Endothelium-derived hyperpolarising factors and associated pathways: a synopsis
Edwards, G., Félétou, M., & Weston, A. H. (2010) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-010-0817-1 · Cited by 360
Comprehensive alpha, beta and delta cell transcriptomes reveal that ghrelin selectively activates delta cells and promotes somatostatin release from pancreatic islets
DiGruccio, M. R., Mawla, A. M., Donaldson, C. J., Noguchi, G. M., Vaughan, J., Cowing-Zitron, C., van der Meulen, T., & Huising, M. O. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.04.007 · Cited by 353
Regulation of the Pulmonary Circulation in the Fetus and Newborn
Gao, Y., & Raj, J. U. (2010) · Physiological Reviews · doi:10.1152/physrev.00032.2009 · Cited by 357
Role of estrogen receptors in health and disease
Chen, P., Li, B., & Ou-Yang, L. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.839005 · Cited by 339
MOLE 2.0: advanced approach for analysis of biomacromolecular channels
Sehnal, D., Vařeková, R. S., Berka, K., Pravda, L., Navrátilová, V., Banáš, P., Ionescu, C.-M., Otyepka, M., & Koča, J. (2013) · Journal of Cheminformatics · doi:10.1186/1758-2946-5-39 · Cited by 328
The mechanism of action of retigabine (ezogabine), a first‐in‐class K + channel opener for the treatment of epilepsy
Gunthorpe, M. J., Large, C. H., & Sankar, R. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2011.03365.x · Cited by 319
Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake rats
Kehr, J., Ichinose, F., Yoshitake, S., Goiny, M., Sievertsson, T., Nyberg, F., & Yoshitake, T. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01499.x · Cited by 312
The selective sphingosine 1‐phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species‐specific effects on heart rate
Gergely, P. A., Nuesslein‐Hildesheim, B., Guerini, D., Brinkmann, V., Traebert, M., Bruns, C., Pan, S., Gray, N. S., Hinterding, K., Cooke, N., et al. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02061.x · Cited by 307
Monoclonal antibody TGN1412 trial failure explained by species differences in CD28 expression on CD4 + effector memory T‐cells
Eastwood, D., Findlay, L., Poole, S., Bird, C., Wadhwa, M., Moore, M., Burns, C., Thorpe, R., & Stebbings, R. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00922.x · Cited by 300
Signal transduction by protease‐activated receptors
Soh, U. J. K., Dores, M. R., Chen, B., & Trejo, J. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00705.x · Cited by 294
A new ESI-LC/MS approach for comprehensive metabolic profiling of phytocannabinoids in Cannabis
Berman, P., Futoran, K., Lewitus, G. M., Mukha, D., Benami, M., Shlomi, T., & Meiri, D. (2018) · Scientific Reports · doi:10.1038/s41598-018-32651-4 · Cited by 299
High‐throughput screening and small animal models, where are we?
Giacomotto, J., & Ségalat, L. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00725.x · Cited by 295
Sensory and Signaling Mechanisms of Bradykinin, Eicosanoids, Platelet-Activating Factor, and Nitric Oxide in Peripheral Nociceptors
Pethö, G., & Reeh, P. W. (2012) · Physiological Reviews · doi:10.1152/physrev.00048.2010 · Cited by 299
Activity-Dependent Regulation of Synapses by Retrograde Messengers
Regehr, W. G., Carey, M. R., & Best, A. R. (2009) · Neuron · doi:10.1016/j.neuron.2009.06.021 · Cited by 299
5‐HT1Areceptors are involved in the cannabidiol‐induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats
Resstel, L. B. M., Tavares, R. F., Lisboa, S. F. S., Joca, S. R. L., Corrêa, F. M. A., & Guimarães, F. S. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00046.x · Cited by 283
The solute carrier 6 family of transporters
Bröer, S., & Gether, U. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01975.x · Cited by 277
AKT in cancer: new molecular insights and advances in drug development
Mundi, P. S., Sachdev, J., McCourt, C., & Kalinsky, K. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13021 · Cited by 272
Mammalian P2X7 receptor pharmacology: comparison of recombinant mouse, rat and human P2X7 receptors
Donnelly‐Roberts, D. L., Namovic, M. T., Han, P., & Jarvis, M. F. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00233.x · Cited by 271
P2X Receptors as Drug Targets
North, R. A., & Jarvis, M. F. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.083758 · Cited by 271
Physiology of Kidney Renin
Castrop, H., Höcherl, K., Kurtz, A., Schweda, F., Todorov, V., & Wagner, C. (2010) · Physiological Reviews · doi:10.1152/physrev.00011.2009 · Cited by 265
A novel, orally active LPA 1 receptor antagonist inhibits lung fibrosis in the mouse bleomycin model
Swaney, J. S., Chapman, C. W., Correa, L., Stebbins, K. J., Bundey, R., Prodanovich, P., Fagan, P. C., Baccei, C. S., Santini, A. M., Hutchinson, J., et al. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00828.x · Cited by 267
JWH018, a common constituent of ‘Spice’ herbal blends, is a potent and efficacious cannabinoid CB1receptor agonist
Atwood, B. K., Huffman, J. W., Straiker, A. J., & Mackie, K. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00582.x · Cited by 263
Allostery at G Protein-Coupled Receptor Homo- and Heteromers: Uncharted Pharmacological Landscapes
Smith, N. J., & Milligan, G. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.002667 · Cited by 261
Quercetin potentiates insulin secretion and protects INS‐1 pancreatic β‐cells against oxidative damage via the ERK1/2 pathway
Youl, E., Bardy, G., Magous, R., Cros, G. H., Sejalon, F., Virsolvy, A., Richard, S., Quignard, J., Gross, R., Petit, P., et al. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00910.x · Cited by 268
‘Entourage’ effects of N‐palmitoylethanolamide and N‐oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors
Ho, W. ‐. V., Barrett, D. A., & Randall, M. D. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.324 · Cited by 259
Cannabidiol, a non‐psychotropic component of cannabis, attenuates vomiting and nausea‐like behaviour via indirect agonism of 5‐HT1A somatodendritic autoreceptors in the dorsal raphe nucleus
Rock, E., Bolognini, D., Limebeer, C., Cascio, M., Anavi‐Goffer, S., Fletcher, P., Mechoulam, R., Pertwee, R., & Parker, L. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01621.x · Cited by 255
Mechanisms of Resistance to Endocrine Therapy in Breast Cancer: Focus on Signaling Pathways, miRNAs and Genetically Based Resistance
García-Becerra, R., Santos, N. D., Díaz, L., & Camacho, J. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms14010108 · Cited by 261
Δ9‐Tetrahydrocannabinol andN‐arachidonyl glycine are full agonists at GPR18 receptors and induce migration in human endometrial HEC‐1B cells
McHugh, D., Page, J., Dunn, E., & Bradshaw, H. B. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01497.x · Cited by 251
Pharmacological modulation of chemokine receptor function
Scholten, D. J., Canals, M., Maussang, D., Roumen, L., Smit, M. J., Wijtmans, M., de Graaf, C., Vischer, H. F., & Leurs, R. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01551.x · Cited by 250
Identification and characterization of novel TRPV4 modulators
Vincent, F., Acevedo, A., Nguyen, M. T. L., Dourado, M., DeFalco, J., Gustafson, A. E., Spiro, P. A., Emerling, D. E., Kelly, M. G., & Duncton, M. A. J. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.09.007 · Cited by 247
Calcium‐activated potassium channels and endothelial dysfunction: therapeutic options?
Félétou, M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00052.x · Cited by 244
Evidence that the plant cannabinoid cannabigerol is a highly potent α2‐adrenoceptor agonist and moderately potent 5HT1Areceptor antagonist
Cascio, M. G., Gauson, L., Stevenson, L. A., Ross, R., & Pertwee, R. G. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00515.x · Cited by 242
Flavonoid modulation of GABA A receptors
Hanrahan, J. R., Chebib, M., & Johnston, G. A. R. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01228.x · Cited by 246
Antidepressant‐like effects of ginsenoside Rg1 are due to activation of the BDNF signalling pathway and neurogenesis in the hippocampus
Jiang, B., Xiong, Z., Yang, J., Wang, W., Wang, Y., Hu, Z., Wang, F., & Chen, J. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01902.x · Cited by 239
Recommendations for genetic testing to reduce the incidence of anthracycline‐induced cardiotoxicity
Aminkeng, F., Ross, C. J., Rassekh, S. R., Hwang, S., Rieder, M. J., Bhavsar, A. P., Smith, A., Sanatani, S., Gelmon, K. A., Bernstein, D., et al. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13008 · Cited by 236
G-Protein-Coupled Receptors in Intestinal Chemosensation
Reimann, F. M., Tolhurst, G., & Gribble, F. M. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2011.12.019 · Cited by 245
Estrogens and breast cancer: Mechanisms involved in obesity-related development, growth and progression
Bhardwaj, P., Au, C. C., Benito-Martin, A., Ladumor, H., Oshchepkova, S., Moges, R., & Brown, K. A. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.03.002 · Cited by 233
Future Pharmacotherapy for Obesity: New Anti-obesity Drugs on the Horizon
Srivastava, G., & Apovian, C. (2018) · Current Obesity Reports · doi:10.1007/s13679-018-0300-4 · Cited by 232
Exploring avidity: understanding the potential gains in functional affinity and target residence time of bivalent and heterobivalent ligands
Vauquelin, G., & Charlton, S. J. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12106 · Cited by 235
Markedly reduced toxicity of a hydrogen sulphide-releasing derivative of naproxen (ATB-346)
Wallace, J. L., Caliendo, G., Santagada, V., & Cirino, G. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00611.x · Cited by 231
Cannabidiol as potential anticancer drug
Massi, P., Solinas, M., Cinquina, V., & Parolaro, D. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04298.x · Cited by 241
Molecular mechanisms underlying bile acid‐stimulated glucagon‐like peptide‐1 secretion
Parker, H. E., Wallis, K., le Roux, C. W., Wong, K. Y., Reimann, F. M., & Gribble, F. M. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01561.x · Cited by 234
Regulation of RhoGEF proteins by G 12/13 ‐coupled receptors
Siehler, S. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00121.x · Cited by 238
Na v 1.7 and other voltage-gated sodium channels as drug targets for pain relief
Emery, E. C., Luiz, A. P., & Wood, J. N. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1162295 · Cited by 227
The IUPHAR/BPS Guide to PHARMACOLOGY in 2024
Harding, S. D., Armstrong, J. F., Faccenda, E., Southan, C., Alexander, S. P. H., Davenport, A. P., Spedding, M., & Davies, J. A. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkad944 · Cited by 226
Self-citation
Sex differences in micro- and macro-vascular complications of diabetes mellitus
Maric-Bilkan, C. (2017) · Clinical Science · doi:10.1042/cs20160998 · Cited by 217
Non‐THC cannabinoids inhibit prostate carcinoma growthin vitroandin vivo: pro‐apoptotic effects and underlying mechanisms
PETROCELLIS, L. D., Ligresti, A., Moriello, A. S., Iappelli, M., Verde, R., Stott, C. G., Cristino, L., Orlando, P., & Marzo, V. D. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02027.x · Cited by 211
Mechanisms of human inherited epilepsies
Reid, C. A., Berkovic, S. F., & Petrou, S. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.09.016 · Cited by 207
The precursor of resolvin D series and aspirin-triggered resolvin D1 display anti-hyperalgesic properties in adjuvant-induced arthritis in rats
Lima-Garcia, J. F., Dutra, R. C., da Silva, K., Motta, E., Campos, M. M., & Calixto, J. Β. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01345.x · Cited by 208
The complex G protein‐coupled receptor kinase 2 (GRK2) interactome unveils new physiopathological targets
Penela, P., Murga, C., Ribas, C., Lafarga, V., & Mayor, F. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00727.x · Cited by 205
Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ ‐47965567
Bhattacharya, A., Wang, Q., Ao, H., Shoblock, J. R., Lord, B., Aluisio, L. E., Fraser, I. C., Nepomuceno, D. H., Neff, R. A., Welty, N., et al. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12314 · Cited by 204
The endocannabinoid system and cancer: therapeutic implication
Guindon, J., & Hohmann, A. G. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01327.x · Cited by 210
Novel pyrazole compounds for pharmacological discrimination between receptor‐operated and store‐operated Ca 2+ entry pathways
Schleifer, H., Doleschal, B., Lichtenegger, M., Oppenrieder, R., Derler, I., Frischauf, I., Glasnov, T., Kappe, C. O., Romanin, C., & Groschner, K. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02126.x · Cited by 198
Depression‐resistant endophenotype in mice overexpressing cannabinoid CB 2 receptors
García‐Gutiérrez, M., Pérez‐Ortiz, J., Gutiérrez‐Adán, A., & Manzanares, J. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00819.x · Cited by 196
Use of inotropes and vasopressor agents in critically ill patients
Bangash, M. N., Kong, M., & Pearse, R. M. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01588.x · Cited by 196
Comparative neuropharmacology of three psychostimulant cathinone derivatives: butylone, mephedrone and methylone
López‐Arnau, R., Martínez-Clemente, J., Pubill, D., Escubedo, E., & Camarasa, J. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01998.x · Cited by 196
EDHF: spreading the influence of the endothelium
Garland, C. J., Hiley, C. R., & Dora, K. A. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01148.x · Cited by 195
PGE 2 ‐EP 2 signalling in endothelium is activated by haemodynamic stress and induces cerebral aneurysm through an amplifying loop via NF‐κB
Aoki, T., Nishimura, M., Matsuoka, T., Yamamoto, K., Furuyashiki, T., Kataoka, H., Kitaoka, S., Ishibashi, R., Ishibazawa, A., Miyamoto, S., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01358.x · Cited by 193
A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodents
Cluny, N. L., Vemuri, K. V., Chambers, A., Limebeer, C. L., Bedard, H., Wood, J., Lutz, B., Zimmer, A., Parker, L., Makriyannis, A., et al. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00908.x · Cited by 194
The IUPHAR/BPS Guide to PHARMACOLOGY in 2020: extending immunopharmacology content and introducing the IUPHAR/MMV Guide to MALARIA PHARMACOLOGY
Armstrong, J. F., Faccenda, E., Harding, S. D., Pawson, A. J., Southan, C., Sharman, J. L., Campo, B., Cavanagh, D. R., Alexander, S. P. H., Davenport, A. P., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz951 · Cited by 186
Self-citation
Endothelial Ca2+‐activated K+channels in normal and impaired EDHF–dilator responses – relevance to cardiovascular pathologies and drug discovery
Grgic, I., Kaistha, B. P., Hoyer, J. D., & Köhler, R. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00132.x · Cited by 191
Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis‐like disease in C57BL/6 mice
Kozela, E., Lev, N., Kaushansky, N., Eilam, R., Rimmerman, N., Levy, R., Ben‐Nun, A., Juknat, A., & Vogel, Z. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01379.x · Cited by 201
Carbon Monoxide, Hydrogen Sulfide, and Nitric Oxide as Signaling Molecules in the Gastrointestinal Tract
Farrugia, G., & Szurszewski, J. H. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.04.041 · Cited by 192
Cannabidivarin‐rich cannabis extracts are anticonvulsant in mouse and rat via a CB1 receptor‐independent mechanism
Hill, T. D. M., Cascio, M. G., Romano, B., Duncan, M., Pertwee, R. G., Williams, C. M., Whalley, B. J., & Hill, A. J. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12321 · Cited by 189
Phytocannabinoids beyond the Cannabis plant – do they exist?
Gertsch, J., Pertwee, R. G., & Di Marzo, V. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00745.x · Cited by 188
Chemokine receptor CCR5: from AIDS to atherosclerosis
Jones, K. L., Maguire, J. J., & Davenport, A. P. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01147.x · Cited by 188
ArachnoServer 2.0, an updated online resource for spider toxin sequences and structures
Herzig, V., Wood, D., Newell, F., Chaumeil, P.-A., Kaas, Q., Binford, G. J., Nicholson, G. M., Gorse, A., & King, G. F. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq1058 · Cited by 184
The pharmacological challenge to tame the transient receptor potential vanilloid‐1 (TRPV1) nocisensor
Holzer, P. D. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.351 · Cited by 184
The hydrogen sulfide donor, GYY 4137, exhibits anti‐atherosclerotic activity in high fat fed apolipoprotein E −/− mice
Liu, Z., Han, Y., Li, L., Lu, H., Meng, G., Li, X., Atan, M. S. B. M., Peh, M. T., Xie, L., Zhou, S., et al. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12246 · Cited by 181
The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis
Romano, B., Borrelli, F., Fasolino, I., Capasso, R., Piscitelli, F., Cascio, M. G., Pertwee, R. G., Coppola, D., Vassallo, L. M., Orlando, P., et al. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12120 · Cited by 181
Proteinase-activated receptors (PARs) – focus on receptor-receptor-interactions and their physiological and pathophysiological impact
Gieseler, F., Ungefroren, H., Settmacher, U., Hollenberg, M. D., & Kaufmann, R. (2013) · Cell Communication and Signaling · doi:10.1186/1478-811x-11-86 · Cited by 189
Resolvin D1 attenuates activation of sensory transient receptor potential channels leading to multiple anti‐nociception
Bang, S., Yoo, S., Yang, T., Cho, H., Kim, Y., & Hwang, S. W. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00909.x · Cited by 176
Non‐psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of action
Maione, S., Piscitelli, F., Gatta, L., Vita, D. D., PETROCELLIS, L. D., Palazzo, E., de Novellis, V., & Marzo, V. D. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01063.x · Cited by 186
GPCRs: Emerging anti-cancer drug targets
Nieto, A., & McDonald, P. H. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.09.005 · Cited by 173
The participation of plasma membrane hemichannels to purinergic signaling
Baroja‐Mazo, A., Barberà-Cremades, M., & Pelegrı́n, P. (2012) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2012.01.002 · Cited by 178
Cannabidivarin is anticonvulsant in mouse and rat
Hill, A. G., Mercier, M., Hill, T., Glyn, S., Jones, N., Yamasaki, Y., Futamura, T., Duncan, M., Stott, C., Stephens, G. J., et al. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02207.x · Cited by 179
Metformin inhibits P‐glycoprotein expression via the NF‐κB pathway and CRE transcriptional activity through AMPK activation
Kim, H. G., Hiền, T. T., Han, E. H., Hwang, Y. P., Choi, J. H., Kang, K. W., Kwon, K., Kim, B., Kim, S. K., Song, G., et al. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01101.x · Cited by 175
Inhibitory effect of cannabichromene, a major non‐psychotropic cannabinoid extracted from Cannabis sativa, on inflammation‐induced hypermotility in mice
Izzo, A. A., Capasso, R., Aviello, G., Borrelli, F., Romano, B., Piscitelli, F., Gallo, L., Capasso, F., Orlando, P., & Marzo, V. D. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01879.x · Cited by 171

Authors: Alexander, S., Mathie, A., & Peters, J.
Affiliations: University of Nottingham (GB)
Medway School of Pharmacy (GB)
University of Dundee (GB)
ORCID: Mathie, A
Venue: British Journal of Pharmacology
Publisher: Wiley
Published: 2011-11
Volume: 164
Issue: s1
Pages: S1-324
ISSN: 0007-1188 (ISSN-L)
1476-5381
DOI: 10.1111/j.1476-5381.2011.01649_1.x
PMC: PMC3315626
OpenAlex: W2069380892
Cited by: 1,947
References: 2
Citations by year: 2026: 4 · 2025: 13 · 2024: 12 · 2023: 14 · 2022: 23 · 2021: 19 · 2020: 20 · 2019: 35 · 2018: 27 · 2017: 36 · 2016: 47 · 2015: 59 · 2014: 71 · 2013: 191 · 2012: 279
FWCI: 109.61
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: British Journal of Pharmacology (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Discovery Research Portal (University of Dundee) (submittedVersion)
Kent Academic Repository (University of Kent) (submittedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords: therapeutic target, G protein-coupled receptors, ligand-gated ion channels, ion channels, nuclear receptors, transporters, enzymes, receptor nomenclature, pharmacological tools
MeSH terms: Animals, Humans, Ion Channels, Receptors, Cell Surface, Receptors, Cytoplasmic and Nuclear

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Guide to Receptors and Channels (GRAC), 5th edition

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks